126 related articles for article (PubMed ID: 11691808)
1. A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.
Adachi Y; Reynolds PN; Yamamoto M; Wang M; Takayama K; Matsubara S; Muramatsu T; Curiel DT
Cancer Res; 2001 Nov; 61(21):7882-8. PubMed ID: 11691808
[TBL] [Abstract][Full Text] [Related]
2. Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.
Adachi Y; Reynolds PN; Yamamoto M; Grizzle WE; Overturf K; Matsubara S; Muramatsu T; Curiel DT
Cancer Res; 2000 Aug; 60(16):4305-10. PubMed ID: 10969765
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
[TBL] [Abstract][Full Text] [Related]
4. Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.
Uchino J; Takayama K; Harada A; Kawakami Y; Inoue H; Curiel DT; Nakanishi Y
Cancer Gene Ther; 2005 Sep; 12(9):737-48. PubMed ID: 15861179
[TBL] [Abstract][Full Text] [Related]
5. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
[TBL] [Abstract][Full Text] [Related]
6. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma.
Leung W; Chen AR; Klann RC; Moss TJ; Davis JM; Noga SJ; Cohen KJ; Friedman AD; Small D; Schwartz CL; Borowitz MJ; Wharam MD; Paidas CN; Long CA; Karandish S; McMannis JD; Kastan MB; Civin CI
Bone Marrow Transplant; 1998 Nov; 22(10):971-9. PubMed ID: 9849694
[TBL] [Abstract][Full Text] [Related]
7. Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model.
Terao S; Shirakawa T; Kubo S; Bishunu A; Lee SJ; Goda K; Tsukuda M; Hamada K; Tagawa M; Takenaka A; Fujisawa M; Gotoh A
Urology; 2007 Nov; 70(5):1009-13. PubMed ID: 17919690
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
9. Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation.
Wu A; Mazumder A; Martuza RL; Liu X; Thein M; Meehan KR; Rabkin SD
Cancer Res; 2001 Apr; 61(7):3009-15. PubMed ID: 11306480
[TBL] [Abstract][Full Text] [Related]
10. Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects.
Lang P; Pfeiffer M; Müller I; Schumm M; Ebinger M; Koscielniak E; Feuchtinger T; Föll J; Martin D; Handgretinger R
Klin Padiatr; 2006; 218(6):321-6. PubMed ID: 17080334
[TBL] [Abstract][Full Text] [Related]
11. Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy.
Kohno S; Nakagawa K; Hamada K; Harada H; Yamasaki K; Hashimoto K; Tagawa M; Nagato S; Furukawa K; Ohnishi T
Oncol Rep; 2004 Jul; 12(1):73-8. PubMed ID: 15201962
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines.
Zanini C; Giribaldi G; Mandili G; Carta F; Crescenzio N; Bisaro B; Doria A; Foglia L; di Montezemolo LC; Timeus F; Turrini F
J Neurochem; 2007 Nov; 103(4):1344-54. PubMed ID: 17680992
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
[TBL] [Abstract][Full Text] [Related]
14. [hTERT promoter-based conditionally replicative adenoviruses are useful for lung cancer and other solid cancer treatment].
Uchino J; Takayama K; Harada A; Kawakami Y; Inoue H; Curiel DT; Nakanishi Y
Fukuoka Igaku Zasshi; 2009 Nov; 100(11):338-48. PubMed ID: 20391937
[TBL] [Abstract][Full Text] [Related]
15. A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11.
Meck MM; Wierdl M; Wagner LM; Burger RA; Guichard SM; Krull EJ; Harris LC; Potter PM; Danks MK
Cancer Res; 2001 Jul; 61(13):5083-9. PubMed ID: 11431345
[TBL] [Abstract][Full Text] [Related]
16. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
[TBL] [Abstract][Full Text] [Related]
17. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
Kirby TO; Rivera A; Rein D; Wang M; Ulasov I; Breidenbach M; Kataram M; Contreras JL; Krumdieck C; Yamamoto M; Rots MG; Haisma HJ; Alvarez RD; Mahasreshti PJ; Curiel DT
Clin Cancer Res; 2004 Dec; 10(24):8697-703. PubMed ID: 15623655
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with conditionally replicating adenovirus and replication defective adenovirus.
Lee CT; Park KH; Yanagisawa K; Adachi Y; Ohm JE; Nadaf S; Dikov MM; Curiel DT; Carbone DP
Cancer Res; 2004 Sep; 64(18):6660-5. PubMed ID: 15374981
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
[TBL] [Abstract][Full Text] [Related]
20. Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells.
Yu L; Hamada K; Namba M; Kadomatsu K; Muramatsu T; Matsubara S; Tagawa M
Eur J Cancer; 2004 Jul; 40(11):1787-94. PubMed ID: 15251170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
